TKNO: Teknova Inc Projected Price to Earnings

Alpha Teknova, Inc. (TKNO) focuses on scaling the production of liquid media for cell therapy, seeking to monetize existing capacities amid rising demand. The business faces pressure from chemical behemoths in the vaccine reagent segment. The current figure is 0.00. This price chart illustrates value trends, reflecting the price action of this medical equipment manufacturer.

TKNO - Teknova Market Cap to Projected Earnings over the range 07/04/2022 - 11/14/2026

Analytical breakdowns and data insights for company Teknova Inc (TKNO)

- stock value and consensus price forecast:

Price Chart Teknova|TKNO - Price Target Chart

- market capitalization information:

Market Valuation Alpha Teknova, Inc.|TKNO - Value Adjusted for Debt and Cash

- issuer book value statistics:

Book Value per Share Teknova|TKNO - Book Valuation of Business|Market Value to Book Value Ratio teknova.com|TKNO - Total Business Assets

- debt burden and liquidity indicators:

Debt to Equity Alpha Teknova, Inc.|TKNO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Alpha Teknova, Inc.|TKNO - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio Alpha Teknova, Inc.|TKNO - Company Long-Term Loans and Borrowings|Company Current Liabilities Teknova|Quick Liquidity teknova.com

- earnings and market ratios statistics:

TKNO - Net Income|Projected Future Earnings Alpha Teknova, Inc.|TKNO - Market Cap to Earnings|Future Price to Earnings Alpha Teknova Inc|TKNO - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio Alpha Teknova, Inc.|TKNO - Company profit before taxes, interest and amortization|Earnings per share for the last twelve months Teknova|TKNO - Net earnings per share for the last four quarters|Quarterly EPS earnings growth teknova.com|TKNO - Earnings growth in current year|Net earnings per share growth forecast for next year Alpha Teknova, Inc.

- revenue and sales proceeds data:

TKNO - Company Revenue|Company Projected Revenue Teknova|TKNO - Price-to-Sales Ratio|Forward P/S Multiple Alpha Teknova, Inc.

Summary company analysis:TKNO Teknova

Minimizing fundamental risks requires analyzing assets through the prism of their future returns. This ratio correlates the current market value of a share with the projected net profit for the coming year, determining the investment payback period. For Alpha Teknova, Inc. (TKNO), this calculation reflects market expectations for demand for specialized reagents in the gene therapy sector. By analyzing the company's forward 12-month P/E, an investor assesses the fairness of the earnings premium. Extremes on this chart signal the limit of market consensus.

Direct competitors